Third party deposit system hits obstacle

Published: 2009-06-02 06:58:00

Updated: 2009-06-02 06:58:00

The third-party deposit system, which has been strongly backed by the Korea Pharmaceutical Manufacturers Association, is likely to hit a snag as many Korean pharmaceutical companies want to make direct contributions to large-sized congresses or seminars.

“Organizers for local cancer or hyperte...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK